Search clinical trials for: Innohep (Tinzaparin)

Total 219 results

University of Aarhus
Aarhus University Hospital; LEO Pharma

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation

Denmark
King Saud University
King AbdulAziz City for Science and Technology

Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS)

Bleeding | Venous Thromboembolism

Saudi Arabia
Assistance Publique - Hôpitaux de Paris
LEO Pharma

Completed

Therapeutic Anticoagulation Strategy for Acute Chest Syndrome (TASC)

Anemia | Acute Chest Syndrome | Sickle Cell | Low-Molecular-Weight Heparin

France
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
LEO Pharma

Completed

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Deep Vein Thrombosis

Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
University Hospital, Linkoeping
Vastra Gotaland Region; Region Jönköping County; Region Västerbotten; Västervik...

Recruiting

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Epithelial Ovarian Cancer

Sweden
Duke University
Celgene Corporation

Completed

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Primary Brain Tumor

United States
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
LEO Pharma

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism

France
Christine Ribic
McMaster University; LEO Pharma

Completed

Use of Tinzaparin for Anticoagulation in Hemodialysis (HEMO-TIN)

Kidney Failure, Chronic

Canada
Ottawa Hospital Research Institute

Recruiting

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Thrombocytopenia | Cancer-associated Thrombosis

Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Hospital Universitari de Bellvitge
LEO Pharma

Completed

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Venous Thromboembolism

Spain
Cardiff University
National Institute for Health Research, United Kingdom; Wales Cancer Trials...

Terminated

Anticoagulation Length in Cancer Associated Thrombosis (ALICAT)

Cancer | Thrombosis | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United Kingdom
Complejo Hospitalario Xeral-Calde
LEO Pharma

Completed

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Acute Pulmonary Embolism

Spain
Aalborg University Hospital
Aalborg University

Completed

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

Deep Venous Thrombosis

Denmark
Ain Shams University

Unknown

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

Fetal Growth Restriction | Fetal Growth Abnormality

Egypt
LEO Pharma

Completed

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Venous Thromboembolism

Canada
Michalis Karamouzis

Recruiting

The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer (imPaCT-PRO)

Pancreatic Cancer | Thromboembolism

Greece
Woman's Health University Hospital, Egypt

Unknown

Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome

Recurrent Pregnancy Losses | Positive Anti Phospholipid Syndrome

Egypt
National Institute of Neurological Disorders and...

Completed

Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) (CATALIST)

Ischemic Stroke

United States
Tampere University Hospital

Recruiting

Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients (Tinza-SLEDD)

Acute Kidney Injury | Renal Replacement Therapy | Anticoagulants

Finland
Assistance Publique - Hôpitaux de Paris

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia

France
Ribe County Hospital
LEO Pharma; Coloplast A/S

Terminated

MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

Inflammation | Peritoneal Dialysis | Nutrition

Denmark
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
University of Vermont
National Cancer Institute (NCI)

Unknown

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
University of Southern California
Celgene Corporation

Terminated

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Cancer | Venous Thromboembolism

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
Herlev Hospital

Recruiting

Study of Low Molecular Weight Heparins (DANHEP)

Venous Thromboembolism | Treatment | Prophylaxis | Anticoagulant

Denmark
Helsinki University Central Hospital

Recruiting

Pre- vs. Postoperative Thromboprophylaxis in Pancreatic Surgery (PREPOSTEROUS2)

Thrombosis | Bleeding | Surgery | Pancreas Cancer | Pancreas Neoplasm

Finland
Anemia Working Group Romania

Withdrawn

Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

Diabetes Mellitus | Hemodialysis

Romania
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (CORIMMUNO-COAG)

COVID19 Pneumonia

France
Helsinki University Central Hospital
Academy of Finland; The Finnish Medical Association

Recruiting

Pre- vs Postoperative Thromboprophylaxis for Liver Resection (PREPOSTEROUS)

Bleeding | Surgery | Liver Cancer | Embolism, Pulmonary | Thrombosis, Deep Vein

Norway, Finland
Assistance Publique - Hôpitaux de Paris

Completed

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) (TILT)

Lung Cancer | Non Small Cell Lung Cancer

France
Central Finland Hospital District

Completed

BEMER in the Treatment of Pain in Fibromyalgia. (Fibromyalgia)

Fibromyalgia

Finland
Sunnybrook Health Sciences Centre
LEO Pharma; Sunnybrook Research Institute

Terminated

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (TILE)

Deep Vein Thrombosis | Post Thrombotic Syndrome

Canada
Lawson Health Research Institute

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Kidney Failure

Canada
Pfizer

Completed

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Acute Coronary Syndrome

India
Centre Hospitalier Universitaire, Amiens

Recruiting

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis (Aticks Live)

Inflammatory Response | Deep Vein Thrombosis

France
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Pfizer

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism

United States, Norway, Russian Federation, Slovenia, Spain

Search clinical trials for: Innohep (Tinzaparin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations